JIANGSU HUAYI RADIOPHARMACEUTICALS CO LTD
Overview
JIANGSU HUAYI RADIOPHARMACEUTICALS CO LTD is an active pharmaceutical ingredient (API) supplier with 5 active FDA Type II Drug Master Files, covering DOTATATE ACETATE; GOZETOTIDE FOR RADIOPHARMACEUTICAL PREPARATIONS (PSMA-11); HYDROXY METHYLENE DIPHOSPHONIC ACID; METHYLENEDIPHOSPHONIC ACID RADIOPHARMACEUTICAL PREPARATIONS; PSMA-I&T FOR RADIOPHARMACEUTICAL PREPARATIONS.
API / Drug Master Files
JIANGSU HUAYI RADIOPHARMACEUTICALS CO LTD holds 6 active (6 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- TERT-BUTYL O-[2-(TOSYLOXY)ETHYL]-N-TRITYL-L-TYROSINATEActive2026-05-26
- HYDROXY METHYLENE DIPHOSPHONIC ACIDActive2026-02-27
- PSMA-I&T FOR RADIOPHARMACEUTICAL PREPARATIONSActive2026-02-12
- DOTATATE ACETATEActive2025-04-02
- METHYLENEDIPHOSPHONIC ACID RADIOPHARMACEUTICAL PREPARATIONSActive2024-09-16
- GOZETOTIDE FOR RADIOPHARMACEUTICAL PREPARATIONS (PSMA-11)Active2023-10-18
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to JIANGSU HUAYI RADIOPHARMACEUTICALS CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this JIANGSU HUAYI RADIOPHARMACEUTICALS CO LTD? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.